Covid-19 in Ocrelizumab-treated people with Multiple Sclerosis
January 25, 2021This article, written by the Journal of Multiple Sclerosis and related disorders, (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum.read more